Skip to main content

For Patients


GNE Myopathy, also known as HIBM, is an adult onset genetic disorder affecting people of all ethnicities, but more prevalent in people of Jewish, Iranian, Indian, Irish, Scottish and Japanese descent. There are currently 2 potential treatments in the works, and NDF is pursuing gene therapy in this area. Genetic screening is encouraged to avoid passing down the gene to future generations.

To view our 2020 GNEM Symposium Speaker Series please click here

To view our webinars please click here


Dr. Rosenbaum Congratulates NDF on Initiating the Pre-IND for Gene Therapy